Startups
Weave Bio
San Francisco, California, United States
Weave Bio, branded Weave, develops an AI-native enterprise platform for regulatory content and knowledge management in drug development. Founded in2022 and headquartered in San Francisco, it uses large language models and structured source traceability to extract scientific information, draft and review regulatory dossiers, and maintain the living record of a therapeutic program. Submission Builder, originally AutoIND, supports investigational and marketing applications; HAQ Manager helps prepare responses to health-authority questions. Pharmaceutical and biotech teams, CROs and consultants retain human scientific and regulatory oversight. Current co-founders Brandon Rice and Ari Caroline serve as CEO and Chief Strategy Officer, supported by seven published strategic advisers. Umut Eser is also a confirmed co-founder, without assuming a current executive position. The company announced a USD10M seed inMay2024, co-led by Innovation Endeavors and Magnetic Ventures, and a USD20M SeriesA inOctober2025 led by USVP. The USD36M total reported with that financing is cumulative capital, not another cash round. Weave Bio is distinct from dental communications companygetweave.com and coding-spend analytics companyweaveos.com. Its AI supports therapeutic development workflows; this is a software platform, without a claim of its own approved therapy.
Founded 2022
Team
 Andrew S. RobertsonStrategic Advisory Board Member |
 Ari CarolineCo-founder and Chief Strategy Officer |
 Brandon RiceCo-founder and Chief Executive Officer |
 Chris LeeStrategic Advisory Board Member |
 Matt GarrattBoard Member |
 Russ AltmanStrategic Advisory Board Member |
 Sean KhozinStrategic Advisory Board Member |
 Stewart HenStrategic Advisory Board Member |
 Tala FakhouriStrategic Advisory Board Member |
 Umut EserCo-founder |
 Vada PerkinsStrategic Advisory Board Member |